Article
Brochure
Executive Resource
Insight Hub
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Success StoryNoncompete litigation and lost profits claims may depend on unsupported assumptions. See how Weaver clarified financial, regulatory and market realities.
A shift in Affordable Care Act (ACA) exchange volume could reshape payer mix and earnings. Explore the health care valuation implications.
Shifting imaging volumes and competitive pressure challenged a hospital. Learn how our valuation analysis helped the hospital plan for a joint venture.
Four interested buyers. Operational and financial hurdles. A new ambulatory surgery center at a crossroads. Learn how Weaver guided valuation strategy.
Published by Medical Journal-Houston, Weaver's Corey Palasota explains the real reason behind how Houston's health care provider landscape has shifted in the past year.
PodcastExplore regulatory drivers, private equity consolidation and emerging trends influencing health care valuation today.
Texas life sciences in 2025 saw concentrated capital, declining innovation output and earlier‑stage clinical shifts shaping the ecosystem.
Get ahead of the curve by looking back at emerging trends in 2025 that are likely to impact health care valuation in 2026 and beyond. Download Weaver Insights now.
Texas life sciences saw record capital in Q4 2025, even as innovation, early-stage funding and late-phase clinical trials continued to decline.
PET, CT and MRI volumes are accelerating. Learn what uneven imaging growth means for valuation and long-term planning.
Growth strategies in behavioral health are shifting. Learn how leaders can respond to industry headwinds and optimize performance effectively.
Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
